About Chad Friesen
Form D filings for XOStem Biosciences from 2020 to 2024 list Chad Friesen as director.
Chad Friesen first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Chad Friesen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chad Friesen works with at each company, as listed on that company's latest Form D.
XOStem Biosciences Ltd. · Form D, Feb 29, 2024
JL
Jonathan Lakey
Executive officer and director
AM
Alex McAulay
CFO and director